June 2026
Published Jun 12, 2026Randomized Controlled Trial
This 12-week trial tested oxygen-enriched ELO water as an add-on therapy in adults with type 2 diabetes. HbA1c fell modestly in the ELO group, especially by week 6 compared with placebo, but fasting glucose and body weight did not clearly improve.
Interventions
Oxygen-enriched water
Outcomes
Adverse events incidenceBody weightFasting blood sugar (FBS)+2 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Cluster Randomized Controlled Trial
This cluster-randomized trial tested a community-based peer-support lifestyle program in 1,007 high-risk Indian adults. The program improved diet, reduced alcohol use, and enhanced physical functioning, but the 14.9% vs 17.1% reduction in diabetes incidence was not statistically significant.
Interventions
Peer-support lifestyle program
Outcomes
Alcohol useFruit and vegetable intakeIndian Diabetes Risk Score+2 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Randomized Controlled Trial
This trial tested whether adults with prediabetes could start and maintain resistance training. After a supervised 3-month training phase, about one-third of participants were no longer prediabetic, and this was mostly maintained through 15 months. Extra social-cognitive support did not outperform lower-contact standard care.
Interventions
Behavioral counselingResistance training
Outcomes
2-hour plasma glucoseAdverse events incidenceFasting blood sugar (FBS)+5 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026RCTs
This study evaluated the effects of a multi-species synbiotic preparation on metabolic profiles in elderly patients with type 2 diabetes and high cardiovascular risk, finding significant reductions in weight, cholesterol, and glucose levels.
Interventions
Synchronous online type 1 diabetes psychoeducational program for school staff
Outcomes
Body Mass Index (BMI) changeBody fat mass (BFM) changeFasting blood sugar (FBS)+5 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Randomized Controlled Trial
This small trial analysis tested daily tadalafil in people with type 2 diabetes. Tadalafil lowered some blood biomarkers related to amyloid metabolism and astroglial activation, but it did not change several other brain-related biomarkers.
Outcomes
Amyloid-β 40Amyloid-β 42Amyloid-β 42/40 ratio+6 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Non Randomized Controlled Trial
This study tested monthly physiotherapist-led exercise guidance supported by wearable device feedback in people with type 2 diabetes, including diabetic kidney disease. Over six months, the intervention group walked farther and had lower HbA1c than the standard care group, while kidney filtration did not clearly change.
Interventions
Exercise therapy
Outcomes
6-minute walk distanceAdverse events incidenceEstimated glomerular filtration rate+3 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Randomized Controlled Trial
This trial tested a carob-based liquid concentrate in people with confirmed prediabetes. After 90 days, the supplement group had better HbA1c, glucose responses, and insulin-related markers than the placebo group, with no adverse effects reported.
Interventions
Carob liquid concentrate
Outcomes
Adverse events incidenceFasting blood sugar (FBS)Fasting insulin levels+5 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Quasi Experimental Study
This study tested a community lifestyle programme for adults with prediabetes in Malaysia. After 12 months, people in the programme had lower blood sugar, better cholesterol, smaller waists, and improved quality of life compared to those receiving usual care. The programme was delivered through existing community volunteers.
Interventions
Lifestyle intervention for prediabetes
Outcomes
2-hour plasma glucoseBody weightDiastolic blood pressure+6 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Cohort
This study investigated the effects of dapagliflozin on the renin-angiotensin-aldosterone system in patients with type 2 diabetes, finding significant changes in several metabolic parameters.
Interventions
Dapagliflozin
Outcomes
BMIDiastolic blood pressureFasting blood sugar (FBS)+8 more
Added to Dediabetes Jun 12, 2026
View studyPublished Jun 12, 2026Secondary Analysis Of A Cluster Randomised Controlled Trial
This study looked at whether attending more sessions of a diabetes prevention programme helped lower type 2 diabetes risk. People who went to all sessions had an 88% lower risk of developing diabetes compared to those receiving standard care. However, fewer than 1 in 3 people attended all sessions.
Interventions
Lifestyle intervention for prediabetes
Outcomes
2-hour plasma glucoseAnxiety scoreBody weight+6 more
Added to Dediabetes Jun 12, 2026
View study